Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.

Ishikawa M, Iwasa S, Nagashima K, Aoki M, Imazeki H, Hirano H, Shoji H, Honma Y, Okita N, Takashima A, Kato K, Saruta M, Boku N.

Invest New Drugs. 2019 Jul 2. doi: 10.1007/s10637-019-00822-3. [Epub ahead of print]

PMID:
31264067
2.

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer.

Aoki M, Shoji H, Nagashima K, Imazeki H, Miyamoto T, Hirano H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Higuchi K, Boku N.

ESMO Open. 2019 May 21;4(3):e000488. doi: 10.1136/esmoopen-2019-000488. eCollection 2019.

3.

Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer.

Monma S, Kato K, Shouji H, Okita N, Takashima A, Honma Y, Iwasa S, Hamaguchi T, Yamada Y, Shimada Y, Boku N, Nagashima K, Ito Y, Itami J.

Esophagus. 2019 Jun 20. doi: 10.1007/s10388-019-00680-1. [Epub ahead of print]

PMID:
31222680
4.

Handheld flow meter improves COPD detectability regardless of using a conventional questionnaire: A split-sample validation study.

Fujita M, Nagashima K, Takahashi S, Suzuki K, Fujisawa T, Hata A.

Respirology. 2019 Jun 12. doi: 10.1111/resp.13602. [Epub ahead of print]

PMID:
31188538
5.

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).

Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V Study Group.

Diabetes Obes Metab. 2019 Aug;21(8):1990-1995. doi: 10.1111/dom.13750. Epub 2019 May 8.

PMID:
30993861
6.

Inequality within a community at the neighborhood level and the incidence of mood disorders in Japan: a multilevel analysis.

Fujita M, Nagashima K, Takahashi S, Hata A.

Soc Psychiatry Psychiatr Epidemiol. 2019 Mar 22. doi: 10.1007/s00127-019-01687-w. [Epub ahead of print]

PMID:
30903241
7.

Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience.

Matsumura T, Terada J, Yoshimura C, Koshikawa K, Kinoshita T, Yahaba M, Nagashima K, Sakao S, Tatsumi K.

Drug Des Devel Ther. 2019 Feb 28;13:809-816. doi: 10.2147/DDDT.S197237. eCollection 2019.

8.

Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer.

Hiramoto S, Tamaki T, Nagashima K, Hori T, Kikuchi A, Yoshioka A, Inoue A.

Int J Clin Oncol. 2019 Apr;24(4):454-459. doi: 10.1007/s10147-018-1363-7. Epub 2018 Oct 30.

PMID:
30377853
9.

Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.

Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H.

Int J Clin Oncol. 2019 Jan;24(1):60-67. doi: 10.1007/s10147-018-1336-x. Epub 2018 Aug 14.

PMID:
30109544
10.

Medical costs attributable to overweight and obesity in Japanese individuals.

Fujita M, Sato Y, Nagashima K, Takahashi S, Hata A.

Obes Res Clin Pract. 2018 Sep - Oct;12(5):479-484. doi: 10.1016/j.orcp.2018.06.002. Epub 2018 Jun 22.

PMID:
29937133
11.

Imaging peritoneal metastasis of gastric cancer with 18F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept study.

Honma Y, Terauchi T, Tateishi U, Kano D, Nagashima K, Shoji H, Iwasa S, Takashima A, Kato K, Hamaguchi T, Boku N, Shimada Y, Yamada Y.

Br J Radiol. 2018 Sep;91(1089):20180259. doi: 10.1259/bjr.20180259. Epub 2018 Jun 27.

PMID:
29916721
12.

Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.

Nishi T, Kitahara H, Fujimoto Y, Nakayama T, Nagashima K, Hanaoka H, Kobayashi Y.

Heart Vessels. 2018 Dec;33(12):1570-1575. doi: 10.1007/s00380-018-1197-2. Epub 2018 Jun 1.

PMID:
29858919
13.

Prediction intervals for random-effects meta-analysis: A confidence distribution approach.

Nagashima K, Noma H, Furukawa TA.

Stat Methods Med Res. 2019 Jun;28(6):1689-1702. doi: 10.1177/0962280218773520. Epub 2018 May 10.

PMID:
29745296
14.

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.

Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group.

Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21.

PMID:
29685815
15.

Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain.

Watanabe K, Hirano S, Kojima K, Nagashima K, Mukai H, Sato T, Takemoto M, Matsumoto K, Iimori T, Isose S, Omori S, Shibuya K, Sekiguchi Y, Beppu M, Amino H, Suichi T, Yokote K, Uno T, Kuwabara S, Misawa S.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1082-1087. doi: 10.1136/jnnp-2017-316601. Epub 2018 Apr 7.

PMID:
29627772
16.

Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.

Matsumura T, Terada J, Kinoshita T, Sakurai Y, Yahaba M, Tsushima K, Sakao S, Nagashima K, Ozaki T, Kobayashi Y, Hiwasa T, Tatsumi K.

PLoS One. 2018 Mar 29;13(3):e0195015. doi: 10.1371/journal.pone.0195015. eCollection 2018.

17.

Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.

Yamaguchi T, Kato K, Nagashima K, Iwasa S, Honma Y, Takashima A, Hamaguchi T, Ito Y, Itami J, Boku N, Higuchi K.

Int J Clin Oncol. 2018 Aug;23(4):652-658. doi: 10.1007/s10147-018-1258-7. Epub 2018 Mar 8.

PMID:
29520523
18.

Impact of Arterial Stiffness on WatchPAT Variables in Patients With Obstructive Sleep Apnea.

Kinoshita T, Yahaba M, Terada J, Matsumura T, Sakurai Y, Nagashima K, Sakao S, Tatsumi K.

J Clin Sleep Med. 2018 Mar 15;14(3):319-325. doi: 10.5664/jcsm.6970.

19.

The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF).

Kotooka N, Kitakaze M, Nagashima K, Asaka M, Kinugasa Y, Nochioka K, Mizuno A, Nagatomo D, Mine D, Yamada Y, Kuratomi A, Okada N, Fujimatsu D, Kuwahata S, Toyoda S, Hirotani SI, Komori T, Eguchi K, Kario K, Inomata T, Sugi K, Yamamoto K, Tsutsui H, Masuyama T, Shimokawa H, Momomura SI, Seino Y, Sato Y, Inoue T, Node K; HOMES-HF study investigators.

Heart Vessels. 2018 Aug;33(8):866-876. doi: 10.1007/s00380-018-1133-5. Epub 2018 Feb 15.

PMID:
29450689
20.

Heart Rate and Oxygen Saturation Change Patterns During 6-min Walk Test in Subjects With Chronic Thromboembolic Pulmonary Hypertension.

Inagaki T, Terada J, Yahaba M, Kawata N, Jujo T, Nagashima K, Sakao S, Tanabe N, Tatsumi K.

Respir Care. 2018 May;63(5):573-583. doi: 10.4187/respcare.05788. Epub 2017 Dec 26.

Supplemental Content

Loading ...
Support Center